Skip to main content
. 2022 Feb 3;15(2):193. doi: 10.3390/ph15020193

Table 2.

Correlation of 90 percent CIs of Ln-transformed variables for the parent reference empagliflozin after administration of two empagliflozin tablet formulations (test/parent reference).

Compound/Parameter Test/Parent Reference (%) 90% CI p
<80% >125%
Parent Reference Empagliflozin
In Cmax 108.12 95.69–116.99 0.001 0.0029
In AUC0–ƚ 98.40 92.77–110.01 <0.001 <0.001
In AUC0–∞ 96.9 93.19–106.09 <0.001 <0.001